Fisher Asset Management
BMRN icon

Fisher Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Fisher Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
35,480
+190
+0.5% +$11.1K ﹤0.01% 574
2025
Q4 		$2.1M Buy
35,290
+3,564
+11% +$194K ﹤0.01% 552
2025
Q3 		$1.72M Buy
31,726
+18,181
+134% +$1.04M ﹤0.01% 601
2025
Q2 		$745K Sell
13,545
-28
-0.2% -$1.65K ﹤0.01% 732
2025
Q1 		$960K Sell
13,573
-393
-3% -$26.4K ﹤0.01% 686
2024
Q4 		$918K Buy
13,966
+420
+3% +$28.1K ﹤0.01% 670
2024
Q3 		$952K Buy
13,546
+122
+0.9% +$10.2K ﹤0.01% 665
2024
Q2 		$1.11M Sell
13,424
-75
-0.6% -$6.24K ﹤0.01% 668
2024
Q1 		$1.18M Buy
13,499
+9
+0.1% +$806 ﹤0.01% 665
2023
Q4 		$1.3M Buy
+13,490
New +$1.19M ﹤0.01% 655

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return